Accelerate Diagnostics to Review Third Quarter 2018 Results on November 6th

Oct 17, 2018

Accelerate Diagnostics to Review Third Quarter 2018 Results on November 6th

TUCSON, Ariz., Oct. 17, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that it will host a conference call on Tuesday, November 6, 2018 to review the company's third quarter 2018 financial results and commercial progress.

Accelerate Diagnostics, Inc. (PRNewsfoto/Accelerate Diagnostics)

President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will review financial results at 4:15 p.m. ET.

Audio Webcast and Conference Call

Listen to an audio webcast of the call by visiting the events section of the company's investor relations website at ir.axdx.com. A replay of the audio webcast will be available until November 26, 2018.

To participate in the conference call, dial +1.877.883.0383 and enter the conference ID: 0396861

International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference. A replay of the call will be available by telephone at +1.877.344.7529 (U.S.) or +1.412.317.0088 (international) using access code 10124532 until November 26, 2018.

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in about 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and "ACCELERATE PHENOTEST" and diamond shaped logos and marks are trademarks or registered trademarks of Accelerate Diagnostics, Inc.

For more information about the company, its products and technology, or recent publications, visit axdx.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/accelerate-diagnostics-to-review-third-quarter-2018-results-on-november-6th-300733226.html

SOURCE Accelerate Diagnostics, Inc.

Investor Inquiries, Laura Pierson, Accelerate Diagnostics, +1 520 365-3100, lpierson@axdx.com, or Media Contact, Andrew Chasteen, Accelerate Diagnostics, +1 520 365-3100, achasteen@axdx.com

:

Day High:
Day Low:  
Volume:    

Copyright West LLC. Minimum 15 minutes delayed.


Want to receive investor-related news and updates?

Join our mailing list

Other updates